EditForce
Fukuoka
About EditForce
EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.6M
- Last round: Series Unknown (May 2021)
- Website: editforce.co.jp
- Phone: +81 092-802-4935
Industries & Categories
Biotechnology, Medical, Nursing and Residential Care
Canonical: https://fsome.com/organization/editforce-84506 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.